Hypercalcemia worsened after vitamin D supplementation in a sarcoidosis patient: A case report

Abstract

Rationale: There are many causes of hypercalcemia, with hyperparathyroidism and malignancy accounting for 90% of cases. Sarcoidosis and the intake of vitamin D supplements may also cause hypercalcemia, although the occurrence rate is low if only one is involved. We herein report a sarcoidosis patient who developed hypercalcemia after taking cholecalciferol (vitamin D supplement) for a year. Patient concern: A 62-year-old Japanese man presented with hypercalcemia and acute kidney injury along with symptoms of fatigue and appetite loss while being followed up for sarcoidosis. Diagnoses: We determined that a combination of cholecalciferol supplementation and sarcoidosis had led to hypercalcemia for several reasons. First, hypercalcemia had not been noted when this patient had first been admitted due to sarcoidosis-related respiratory failure several years earlier, which we presumed that was the highest sarcoidosis disease activity. Second, low serum 25-OH Vit.D3and high 1,25-(OH)2Vit.D3levels were noted despite cholecalciferol supplementation for a year, suggesting that 1-α-hydroxylase overexpression caused by sarcoidosis accelerated the conversion from 25-OH Vit.D3to 1,25-(OH)2Vit.D3. Interventions: Although initially resistant to preservative management, the hypercalcemia promptly improved after starting corticosteroid treatment. Outcomes: Hypercalcemia and acute kidney injury were normalized after corticosteroid treatment. Lessons: We should be aware of patients' medications, especially in patients with granulomatosis disease. The concomitant measurement of 25-OH Vit.D3and 1,25-(OH)2Vit.D3levels is useful for determining the cause of hypercalcemia.